Numerous individuals seek medical interventions involving cellular therapies outside their home countries. Mexico has emerged as a prominent destination for these procedures. The reasons underpinning this trend are multifaceted, encompassing regulatory landscapes, cost considerations, and perceived access to innovative treatments.
The comparatively less stringent regulations governing cellular therapies in Mexico, compared to countries like the United States or Canada, permit the availability of treatments that are either still in clinical trials or unapproved in those regions. This regulatory environment, coupled with a lower cost of medical care, can make Mexico an attractive option for patients facing high treatment expenses or limited access in their own healthcare systems. Furthermore, the potential for faster access to therapies, bypassing lengthy approval processes in other countries, serves as a significant motivator.
